先天性心疾患用デバイスの世界市場レポート 2025年

先天性心疾患用デバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.2％で41億3,000万米ドルに成長します。予測期間の成長は、臨床試験の増加、高齢者人口の急増、先天性心疾患の有病率の増加、政府支援と資金の増加、専門医療センターの増加などに起因しています。予測期間における主な動向としては、技術の進歩、デジタルヘルス技術、個別化医療、3Dプリンティング技術、ウェアラブルデバイスなどが挙げられます。

先天性心疾患デバイス市場の成長は、低侵襲手術の増加によって牽引されると予測されます。これらの処置は、外傷を最小限に抑え回復を向上させるために特殊なツールや技術を使用し、小さな切開や自然な体の開口部から手術を行うことを含みます。低侵襲手術の増加の要因としては、技術の進歩、侵襲の少ない治療法に対する患者の嗜好、手術技術の向上、回復時間や合併症の減少による利点などが挙げられます。先天性心疾患用デバイスは、より小さな切開やカテーテルを用いたアプローチによって心臓の異常の診断、治療、管理を可能にすることで、これらの処置において重要な役割を果たしています。例えば、米国形成外科学会（ASPS）によると、2022年に米国で行われた美容目的の低侵襲手術は2,367万2,269件で、以前より7％増加しました。このような低侵襲手術の増加は、結果として先天性心疾患装置市場を後押ししています。

先天性心疾患（CHD）機器市場の主要企業は、革新的なソリューションを開発するために戦略的パートナーシップを結ぶことが増えています。こうしたパートナーシップは、リソースや専門知識を組み合わせ、研究開発努力を強化し、市場開拓を拡大し、商業化プロセスを加速することで、CHD機器分野の企業を支援しています。このような協力関係はイノベーションを促進し、業界の成長に貢献します。例えば、2024年5月、インドの製造会社であるSMT（Sahajanand Medical Technologies Pvt Ltd）は、循環器分野の患者ケアを改善するため、インドのMedTech企業であるHeartXとパートナーシップを締結しました。この提携により、サハジャナンド・メディカル・テクノロジーズ社（SMT）は、JOVE VBステントなどHeartX社の最先端ソリューションを取り入れることで、CHD市場におけるプレゼンスを強化します。この提携により、SMTは治療効果を高め、手技を簡素化し、患者の予後を改善する先進的なCHD機器を提供することが可能になります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界先天性心疾患用デバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の先天性心疾患用デバイス市場：成長率分析
• 世界の先天性心疾患用デバイス市場の実績：規模と成長, 2019-2024
• 世界の先天性心疾患用デバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界先天性心疾患用デバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の先天性心疾患用デバイス市場：デバイスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カテーテル
• ペースメーカー
• 単腔ペースメーカー
• デュアルチャンバーペースメーカー
• 両室ペースメーカー
• リードレスペースメーカー
• 植込み型除細動器
• 両室デバイス
• 埋め込み型心臓ループレコーダー
• その他のデバイスタイプ
• 世界の先天性心疾患用デバイス市場欠陥の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心房中隔欠損症
• 心室中隔欠損症
• 房室中隔欠損症
• 三尖弁閉鎖症
• 動脈幹
• その他の欠陥の種類
• 世界の先天性心疾患用デバイス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 学術調査機関
• その他のエンドユーザー
• 世界の先天性心疾患用デバイス市場カテーテルの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バルーンカテーテル
• 診断用カテーテル
• ガイドカテーテル
• 世界の先天性心疾患用デバイス市場ペースメーカーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単腔ペースメーカー
• デュアルチャンバーペースメーカー
• 両室ペースメーカー
• リードレスペースメーカー
• 世界の先天性心疾患用デバイス市場植込み型除細動器のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルチャンバーICD
• デュアルチャンバーICD
• 皮下ICD
• 世界の先天性心疾患用デバイス市場、両心室デバイスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• Crt-P（心臓再同期療法ペースメーカー）
• Crt-D（心臓再同期療法除細動器）
• 世界の先天性心疾患用デバイス市場埋め込み型心電図ループレコーダーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の埋め込み型ループレコーダー
• 皮下埋め込み型ループレコーダー
• 世界の先天性心疾患用デバイス市場、その他のデバイスタイプのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経カテーテル心臓弁
• 心室補助装置（VADS）

第7章 地域別・国別分析

• 世界の先天性心疾患用デバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の先天性心疾患用デバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 先天性心疾患用デバイス市場：競合情勢
• 先天性心疾患用デバイス市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic plc.
• Philips Healthcare
• Boston Scientific Corporation
• W. L. Gore & Associates Inc.
• Masimo Corporation
• Lepu Medical Technology（Beijing）Co. Ltd.
• MicroPort Scientific Corporation
• Stereotaxis Inc.
• Berlin Heart GmbH
• Ventracor Limited
• Syncardia Systems LLC
• On-X Life Technologies Inc.
• Occlutech Holding AG
• Sahajanand Medical Technologies Pvt. Ltd.
• Response Biomedical Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 先天性心疾患用デバイス市場2029：新たな機会を提供する国
• 先天性心疾患用デバイス市場2029：新たな機会を提供するセグメント
• 先天性心疾患用デバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the Congenital heart defect devices industry. This Congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.91 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast period include technological advancements, digital health technologies, personalized medicine, 3D printing technology, and wearable devices.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, according to the American Society of Plastic Surgeons (ASPS), 23,672,269 cosmetic minimally invasive procedures were performed in the United States in 2022, marking a 7% increase from previous years. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Pfizer Inc., Johnson & Johnson, AstraZeneca plc., Abbott Laboratories, GlaxoSmithKline plc., Medtronic plc., Philips Healthcare, Boston Scientific Corporation, W. L. Gore & Associates Inc., Masimo Corporation, Lepu Medical Technology (Beijing) Co. Ltd., MicroPort Scientific Corporation, Stereotaxis Inc., Berlin Heart GmbH, Ventracor Limited, Syncardia Systems LLC, On-X Life Technologies Inc., Occlutech Holding AG, Sahajanand Medical Technologies Pvt. Ltd., Response Biomedical Corporation, Xeltis AG, Procyrion Inc., Heartstitch Inc., Cardia Inc., OSYPKA Medical GmbH

North America was the largest region in the congenital heart defect devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
• 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
• 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
• Subsegments:
• 1) By Catheters: Balloon Catheters; Diagnostic Catheters; Guiding Catheters
• 2) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers
• 3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds; Dual-Chamber Icds; Subcutaneous Icds
• 4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers); Crt-D (Cardiac Resynchronization Therapy Defibrillators)
• 5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders; Subcutaneous Implantable Loop Recorders
• 6) By Other Device Types: Transcatheter Heart Valves; Ventricular Assist Devices (VADS)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca plc.; Abbott Laboratories; GlaxoSmithKline plc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congenital Heart Defect Devices Market Characteristics

3. Congenital Heart Defect Devices Market Trends And Strategies

4. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Congenital Heart Defect Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Congenital Heart Defect Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Congenital Heart Defect Devices Market Growth Rate Analysis
• 5.4. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Congenital Heart Defect Devices Total Addressable Market (TAM)

6. Congenital Heart Defect Devices Market Segmentation

• 6.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Catheters
• Pacemakers
• Single-Chamber Pacemakers
• Dual-Chamber Pacemakers
• Biventricular Pacemakers
• Leadless Pacemakers
• Implantable Cardioverter Defibrillators
• Biventricular Devices
• Implanted Cardiac Loop Recorders
• Other Device Types
• 6.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atrial Septal Defect
• Ventricular Septal Defect
• Atrioventricular Septal Defect
• Tricuspid Atresia
• Truncus Arteriosus
• Other Defect Types
• 6.3. Global Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Academic And Research Institute
• Other End Users
• 6.4. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Balloon Catheters
• Diagnostic Catheters
• Guiding Catheters
• 6.5. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Chamber Pacemakers
• Dual-Chamber Pacemakers
• Biventricular Pacemakers
• Leadless Pacemakers
• 6.6. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Chamber Icds
• Dual-Chamber Icds
• Subcutaneous Icds
• 6.7. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Crt-P (Cardiac Resynchronization Therapy Pacemakers)
• Crt-D (Cardiac Resynchronization Therapy Defibrillators)
• 6.8. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implanted Cardiac Loop Recorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Implantable Loop Recorders
• Subcutaneous Implantable Loop Recorders
• 6.9. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcatheter Heart Valves
• Ventricular Assist Devices (VADS)

7. Congenital Heart Defect Devices Market Regional And Country Analysis

• 7.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congenital Heart Defect Devices Market

• 8.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congenital Heart Defect Devices Market

• 9.1. China Congenital Heart Defect Devices Market Overview
• 9.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congenital Heart Defect Devices Market

• 10.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congenital Heart Defect Devices Market

• 11.1. Japan Congenital Heart Defect Devices Market Overview
• 11.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congenital Heart Defect Devices Market

• 12.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congenital Heart Defect Devices Market

• 13.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congenital Heart Defect Devices Market

• 14.1. South Korea Congenital Heart Defect Devices Market Overview
• 14.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congenital Heart Defect Devices Market

• 15.1. Western Europe Congenital Heart Defect Devices Market Overview
• 15.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congenital Heart Defect Devices Market

• 16.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congenital Heart Defect Devices Market

• 17.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congenital Heart Defect Devices Market

• 18.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congenital Heart Defect Devices Market

• 19.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congenital Heart Defect Devices Market

• 20.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congenital Heart Defect Devices Market

• 21.1. Eastern Europe Congenital Heart Defect Devices Market Overview
• 21.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congenital Heart Defect Devices Market

• 22.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congenital Heart Defect Devices Market

• 23.1. North America Congenital Heart Defect Devices Market Overview
• 23.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congenital Heart Defect Devices Market

• 24.1. USA Congenital Heart Defect Devices Market Overview
• 24.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congenital Heart Defect Devices Market

• 25.1. Canada Congenital Heart Defect Devices Market Overview
• 25.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congenital Heart Defect Devices Market

• 26.1. South America Congenital Heart Defect Devices Market Overview
• 26.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congenital Heart Defect Devices Market

• 27.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congenital Heart Defect Devices Market

• 28.1. Middle East Congenital Heart Defect Devices Market Overview
• 28.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congenital Heart Defect Devices Market

• 29.1. Africa Congenital Heart Defect Devices Market Overview
• 29.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

• 30.1. Congenital Heart Defect Devices Market Competitive Landscape
• 30.2. Congenital Heart Defect Devices Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

31. Congenital Heart Defect Devices Market Other Major And Innovative Companies

• 31.1. Medtronic plc.
• 31.2. Philips Healthcare
• 31.3. Boston Scientific Corporation
• 31.4. W. L. Gore & Associates Inc.
• 31.5. Masimo Corporation
• 31.6. Lepu Medical Technology (Beijing) Co. Ltd.
• 31.7. MicroPort Scientific Corporation
• 31.8. Stereotaxis Inc.
• 31.9. Berlin Heart GmbH
• 31.10. Ventracor Limited
• 31.11. Syncardia Systems LLC
• 31.12. On-X Life Technologies Inc.
• 31.13. Occlutech Holding AG
• 31.14. Sahajanand Medical Technologies Pvt. Ltd.
• 31.15. Response Biomedical Corporation

32. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

34. Recent Developments In The Congenital Heart Defect Devices Market

35. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

• 35.1 Congenital Heart Defect Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Congenital Heart Defect Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Congenital Heart Defect Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer